Read + Share
Amedeo Smart
Independent Medical Education
Huang CT, Lin CA, Su TJ, Yang CY, et al. Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors. BMC Cancer 2023;23:234.PMID: 36915101
Email
LinkedIn
Facebook
Twitter
Privacy Policy